BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21973227)

  • 21. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
    Centorrino F; Mark TL; Talamo A; Oh K; Chang J
    J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
    Hoy T; Singhal PK; Willey VJ; Insinga RP
    Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR; Birnbaum HG; Secnik K; Marynchenko M; Greenberg P; Claxton A
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of attention deficit disorder among preschool age children.
    Suvarna BS; Kamath A
    Nepal Med Coll J; 2009 Mar; 11(1):1-4. PubMed ID: 19769227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported childhood attention-deficit/hyperactivity disorder symptoms are not specific to the disorder.
    Suhr J; Zimak E; Buelow M; Fox L
    Compr Psychiatry; 2009; 50(3):269-75. PubMed ID: 19374973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attention-deficit/hyperactivity disorder, conduct disorder, and young adult intimate partner violence.
    Fang X; Massetti GM; Ouyang L; Grosse SD; Mercy JA
    Arch Gen Psychiatry; 2010 Nov; 67(11):1179-86. PubMed ID: 21041619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community survey of attention-deficit/hyperactivity disorder among primary school pupils in Benin City, Nigeria.
    Ambuabunos EA; Ofovwe EG; Ibadin MO
    Ann Afr Med; 2011; 10(2):91-6. PubMed ID: 21691013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?
    Antshel KM; Faraone SV; Maglione K; Doyle A; Fried R; Seidman L; Biederman J
    Psychol Med; 2009 Aug; 39(8):1325-35. PubMed ID: 19105857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and causes of dysphonia in a large treatment-seeking population.
    Cohen SM; Kim J; Roy N; Asche C; Courey M
    Laryngoscope; 2012 Feb; 122(2):343-8. PubMed ID: 22271658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses.
    McAfee AT; Chilcott KE; Johannes CB; Hornbuckle K; Hauser WA; Walker AM
    Epilepsia; 2007 Jun; 48(6):1075-82. PubMed ID: 17441988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seasonality of mood disorders in adults with lifetime attention-deficit/hyperactivity disorder (ADHD).
    Amons PJ; Kooij JJ; Haffmans PM; Hoffman TO; Hoencamp E
    J Affect Disord; 2006 Apr; 91(2-3):251-5. PubMed ID: 16458365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.
    Kollins SH; McClernon FJ; Fuemmeler BF
    Arch Gen Psychiatry; 2005 Oct; 62(10):1142-7. PubMed ID: 16203959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan.
    Polanczyk G; Rohde LA
    Curr Opin Psychiatry; 2007 Jul; 20(4):386-92. PubMed ID: 17551354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision.
    Schlander M; Schwarz O; Trott GE; Viapiano M; Bonauer N
    Eur Child Adolesc Psychiatry; 2007 Oct; 16(7):430-8. PubMed ID: 17468967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treated Prevalence of Attention-Deficit/Hyperactivity Disorder Increased from 2009 to 2015 Among School-Aged Children and Adolescents in the United States.
    Nyarko KA; Grosse SD; Danielson ML; Holbrook JR; Visser SN; Shapira SK
    J Child Adolesc Psychopharmacol; 2017 Oct; 27(8):731-734. PubMed ID: 28328236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.